Tag: Molnupiravir
Shortage of COVID drugs as virus levels fluctuate
(CNS): Patients suffering the ill effects of COVID-19 in Cayman are struggling to access antiviral drugs such as Paxlovid and Molnupiravir since the Health Services Authority and the major private hospitals appear to have already used up their supplies. Although the trend in the spread of the coronavirus here in the Cayman Islands is in […]
Cayman needs UK nod for kids COVID shots
(CNS): As the Delta variant of SARS-CoV-2 spreads rapidly through the community, including children, the government here must wait for the green light from the UK to begin administering paediatric formulations to children under 12 years old. The US Food and Drug Administration authorised the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for this age […]
COVID pill approved by UK health agency
(CNS): The United Kingdom has become the first country in the world to approve a COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. On Thursday Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) recommended that the drug, Molnupiravir, be administered by physicians as soon as possible following a positive COVID-19 test and within […]
